
What happened
A contributor compared Aehr Test Systems and Super Micro Computer and picked Super Micro, whose FY 2026 revenue rose 77.8% to $39.1 billion versus Aehr's 15.2% decline to $50.0 million.
Why it matters
The contributor now owns Super Micro shares, while four customers each accounted for 10% or more of its net sales in fiscal 2025, so the pick carries concentration risk.
What to watch
Super Micro faces class action lawsuits over potential accounting and export control issues, and its stock was almost delisted last year for failing to file required earnings reports on time; the bet hinges on whether that reputation damage fades.
WHO IT HITSRetail investors weighing AI hardware names, and shareholders in either company deciding which to hold, face a choice shaped by customer concentration and legal risk at both firms, according to this contributor's assessment.
Summaries like this, every morning.
Both companies sit inside the same AI supply chain but at different points and very different sizes. Aehr provides test and burn-in equipment that checks semiconductor reliability before final assembly, while Super Micro builds the rack-scale server systems that house advanced AI chips. That scale gap shows up in the numbers the contributor cites: Aehr's FY 2026 revenue of $50.0 million and a $7.1 million net loss, against Super Micro's FY 2026 revenue of $39.1 billion and net income of $2.2 billion.
The contributor frames the choice around risk as much as growth. Aehr's annual report shows five customers accounting for 70% of net sales, and the contributor calls customer concentration its primary risk, alongside competition from larger systems manufacturers and geopolitical exposure to China and Taiwan. Super Micro's annual report likewise shows four customers each at 10% or more of net sales, and the contributor points to class action lawsuits over potential accounting and export control issues, plus sensitivity to component prices from Nvidia and Intel.
Where this lands may hinge on whether Super Micro's legal and regulatory troubles stay contained. The contributor argues the controversies damaged its reputation but that sales momentum and profitability support a recovery, and flags the higher Forward P/E and P/S multiple on Aehr as reason to prefer the cheaper name. Readers weighing that call should note it rests on one contributor's judgment, not a consensus view.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
ExaWizards will strengthen its business partnership with Fukuoka Financial Group, targeting back-office work a…

Democrats swept the midterms, and Texas elected Gina Hinojosa, who pledged a moratorium on data center constru…

The Nasdaq-100 was 9% below its peak at last Friday's close as investors questioned AI spending, pressuring Nv…

Starting in early 2027, Google will make Gemini, Gemini Notebook, and Google Search off by default for student…

ADNOC signed a deal with OpenAI and G42 to become the world's first energy company deploying OpenAI's Frontier…

In Crazyrouter's paper-trading experiment, 12 configured model routes each started with $10,000 and made one s…
